Our previous studies demonstrated that breast cancer cells with high CD147 expression possess more malignant phenotypes, like cancer metastasis and recurrence, and are associated with poor overall survival and treatment outcomes (Li et al., 2009). This evidence concerns the gene BSG and breast cancer.